Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Tobias Wirenfeldt Klausen
ResearcherPublications, citations & collaboration network
Tobias Wirenfeldt Klausen is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 219 works, 5,110 citations, an h-index of 40 and an i10-index of 106.
219
Works
5,110
Citations
40
h-index
106
i10-index
How has Tobias Wirenfeldt Klausen's publication output changed over time?
ScholarIQpublication output · 2005–2021
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2021.
1
1
5
1
1
1
1
2005201120132016201720182021
What are the most-cited papers on Tobias Wirenfeldt Klausen?
ScholarIQmost cited works
Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
N. Toft, Henrik Birgens, Jonas Abrahamsson, Laimonas Griškevičius, Heléne Hallböök, Mats Heyman, Tobias Wirenfeldt Klausen, ÓG Jónsson, Katrin Palk, Kaie Pruunsild, Petter Quist‐Paulsen, Goda Vaitkevičienė, Kim Vettenranta, Arne Åsberg, Thomas Leth Frandsen, Hanne Vibeke Marquart, Hans O. Madsen, Ulrika Norén‐Nyström, Kjeld Schmiegelow
S149476849. 2017421 CitationsOPEN ACCESS
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, Eva Ellebæk, Marco Donia, Rikke Boedker Holmstroem, Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed, Stine Emilie Weis-Banke, Morten Orebo Holmström, Helle Westergren Hendel, E. Ehrnrooth, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen, Inge Marie Svane
Nature Medicine. 2021213 CitationsOPEN ACCESS
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Claudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum, Hans Torben Mourits‐Andersen, Johan Lanng Nielsen, Bjarne Christensen, Bjarne Anker Jensen, Bjarne Bach Pedersen, Ellen Taaning, Tobias Wirenfeldt Klausen, Henrik Birgens
S27064115. 2005175 Citations
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir, Henrik Birgens, Henrik Frederiksen, Bjarne Anker Jensen, Morten Krogh Jensen, Lars Kjeldsen, Tobias Wirenfeldt Klausen, Herdis Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Ove Juul Nielsen, Torben Plesner, Stanislaw Pulczynski, Inge Helleberg Rasmussen, Dorthe Rønnov‐Jessen, Hans Carl Hasselbalch
Blood. 2013174 CitationsOPEN ACCESS
A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Henrik Birgens, Henrik Frederiksen, Hans Carl Hasselbalch, Inge Helleberg Rasmussen, Ove Juul Nielsen, Lars Kjeldsen, Herdis Larsen, Torben Mourits‐Andersen, Torben Plesner, Dorthe Rønnov‐Jessen, Hanne Vestergaard, Tobias Wirenfeldt Klausen, Claudia Schöllkopf
S153015021. 2013174 CitationsOPEN ACCESS
Related on ScholarIQ
Copenhagen University Hospital
Institution
Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
Paper
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Paper
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Paper
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Paper
A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Paper